SU
Sudeep Pharma Ltd (SUDEEPPHRM)
₹825.15
Mkt cap
₹9,320 Cr
P/E ratio
53.90
P/B
10.55
Div yield
0.18%
ROE
25.20%
ROCE
28.20%
EPS (TTM)
₹15.31
Book value
₹78
52W range
530–883
Sector
Healthcare
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries. [1]
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthHigh
TechnicalsNeutral
52-week range
−6.59% from high₹825
₹530+55.69% from low₹883
Current
₹825.15
Prev close
₹826.00
Day
−0.10%
Price performance
1D
−0.10%
1W
−4.77%
1M
+1.97%
3M
+21.03%
6M
+55.69%
1Y
—
YTD
+38.26%
Financials
FRevenue, profit & margin
P/E ratio
53.9×
SUDEEPPHRM is 58% above the sector median of 34.0×
SUDEEPPHRM53.9×
Sector median34.0×
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 116 | 158 | 125 | 163 | 172 | 182 | |
| Expenses | 85 | 76 | 99 | 81 | 107 | 112 | 120 | |
| Operating Profit | 63 | 39 | 59 | 44 | 55 | 60 | 63 | |
| OPM % | 43% | 34% | 37% | 35% | 34% | 35% | 34% | |
| Other Income | 2 | 2 | 4 | 5 | 10 | 7 | 6 | |
| Interest | 1 | 1 | 2 | 2 | 2 | 1 | 2 | |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | |
| Profit before tax | 62 | 38 | 58 | 44 | 60 | 62 | 63 | |
| Tax % | 21% | 24% | 24% | 29% | 21% | 23% | 23% | |
| Net Profit | 49 | 29 | 44 | 31 | 47 | 48 | 49 | |
| EPS in Rs | 128.13 | 2.95 | 4.54 | 3.17 | 4.71 | 4.20 | 4.33 | |
| Raw PDF |
Earnings
EResults dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
CLast 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
Sas of Jun 202676.16%Promoter
Promoters76.16%
FIIs1.81%0.26
DIIs15.64%2.47
Public6.39%2.21
Ownership trend
Peers
P8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,941.10 | 37.48 | 4,65,735 | 0.82% | 2,710 | +13.58% | 14,612 | +12.76% | 20.53% |
| Divi's Lab. | ₹7,248.50 | 73.36 | 1,92,425 | 0.41% | 751 | +13.44% | 2,831 | +9.52% | 21.97% |
| Torrent Pharma. | ₹4,961.50 | 86.11 | 1,88,720 | 0.77% | 364 | −20.58% | 4,197 | +41.84% | 15.19% |
| Cipla | ₹1,410.60 | 31.84 | 1,13,955 | 0.92% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Zydus Lifesci. | ₹1,108.70 | 20.38 | 1,10,593 | 0.09% | 1,341 | +21.92% | 7,587 | +16.22% | 21.14% |
| Lupin | ₹2,370.50 | 19.06 | 1,08,387 | 0.76% | 1,469 | +101.49% | 7,475 | +31.89% | 29.93% |
| Mankind Pharma | ₹2,507.20 | 51.44 | 1,03,546 | 0.04% | 559 | +34.23% | 3,443 | +11.81% | 13.53% |
| Sudeep Pharma | ₹825.15 | 53.90 | 9,320 | 0.18% | 49 | +10.61% | 182 | +15.73% | 28.18% |
| Median: 157 Co. | ₹432.05 | 34.03 | 1,978 | 0.10% | 15 | +28.10% | 176 | +17.66% | 15.10% |
Filings
DAnnual reports1
Concall transcripts7
Credit ratings2
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 11 Jul - Submission of Newspaper Advertisement for 37th AGM, E-voting and dividend information published in Business Standard (English) and Vadodara Samachar (regional language) on Saturday, 11th July, …Intimation Of Record Date For Payment Of Final Dividend On Equity Shares For The Financial Year 2025-26 10 JulLetter To Shareholders In Relation To Integrated Annual Report Of The Company For The Financial Year 2025-26 10 Jul - Sudeep Pharma schedules 37th AGM on 4 Aug 2026; final dividend record date 23 Jul, payment 7 Aug.Reg. 34 (1) Annual Report. 10 Jul - Sudeep Pharma released FY2025-26 annual report and scheduled AGM on 4 August 2026.Notice Of 37Th Annual General Meeting 10 Jul